These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30642977)

  • 21. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.
    Ito T; Hanabuchi S; Wang YH; Park WR; Arima K; Bover L; Qin FX; Gilliet M; Liu YJ
    Immunity; 2008 Jun; 28(6):870-80. PubMed ID: 18513999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
    Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
    J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejection.
    Wu Q; Gardiner GJ; Berry E; Wagner SR; Lu T; Clay BS; Moore TV; Ferreira CM; Williams JW; Luster AD; Medoff BD; Cannon JL; Sperling AI; Shilling RA
    PLoS One; 2013; 8(8):e72955. PubMed ID: 23967339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
    Round JL; Mazmanian SK
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12204-9. PubMed ID: 20566854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression.
    Chen Y; Shen S; Gorentla BK; Gao J; Zhong XP
    J Immunol; 2012 Feb; 188(4):1698-707. PubMed ID: 22231701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.
    Conrad C; Gregorio J; Wang YH; Ito T; Meller S; Hanabuchi S; Anderson S; Atkinson N; Ramirez PT; Liu YJ; Freedman R; Gilliet M
    Cancer Res; 2012 Oct; 72(20):5240-9. PubMed ID: 22850422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased production of interleukin-17 over interleukin-10 by treg cells implicates inducible costimulator molecule in experimental spondyloarthritis.
    Araujo LM; Fert I; Jouhault Q; Labroquère K; Andrieu M; Chiocchia G; Breban M
    Arthritis Rheumatol; 2014 Sep; 66(9):2412-22. PubMed ID: 24909668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unstable Foxp3+ regulatory T cells and altered dendritic cells are associated with lipopolysaccharide-induced fetal loss in pregnant interleukin 10-deficient mice.
    Prins JR; Zhang B; Schjenken JE; Guerin LR; Barry SC; Robertson SA
    Biol Reprod; 2015 Oct; 93(4):95. PubMed ID: 26224007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation and Functional Specialization of Regulatory T Cells Lead to the Generation of Foxp3 Instability.
    Zhang Z; Zhang W; Guo J; Gu Q; Zhu X; Zhou X
    J Immunol; 2017 Apr; 198(7):2612-2625. PubMed ID: 28228556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
    Gotsman I; Grabie N; Gupta R; Dacosta R; MacConmara M; Lederer J; Sukhova G; Witztum JL; Sharpe AH; Lichtman AH
    Circulation; 2006 Nov; 114(19):2047-55. PubMed ID: 17060381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CARD11 is dispensable for homeostatic responses and suppressive activity of peripherally induced FOXP3
    Policheni A; Horikawa K; Milla L; Kofler J; Bouillet P; Belz GT; O'Reilly LA; Goodnow CC; Strasser A; Gray DH
    Immunol Cell Biol; 2019 Sep; 97(8):740-752. PubMed ID: 31087793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS.
    Lischke T; Hegemann A; Gurka S; Vu Van D; Burmeister Y; Lam KP; Kershaw O; Mollenkopf HJ; Mages HW; Hutloff A; Kroczek RA
    J Immunol; 2012 Jul; 189(1):234-44. PubMed ID: 22661090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics.
    Pace E; Di Sano C; La Grutta S; Ferraro M; Albeggiani G; Liotta G; Di Vincenzo S; Uasuf CG; Bousquet J; Gjomarkaj M
    PLoS One; 2012; 7(12):e48816. PubMed ID: 23251336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond Type 1 Regulatory T Cells: Co-expression of LAG3 and CD49b in IL-10-Producing T Cell Lineages.
    Huang W; Solouki S; Carter C; Zheng SG; August A
    Front Immunol; 2018; 9():2625. PubMed ID: 30510554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.